Loading clinical trials...
Loading clinical trials...
An Open-label Randomized Controlled Trial on Interferon β-1b and Hydroxychloroquine Combination Versus Hydroxychloroquine Alone, as Treatment for COVID-19 Infection
Conditions
Interventions
Interferon Beta-1B
Hydroxychloroquine
Locations
1
Hong Kong
The University of Hong Kong, Queen Mary Hospital
Hong Kong, Hong Kong
Start Date
April 9, 2020
Primary Completion Date
July 1, 2020
Completion Date
July 7, 2020
Last Updated
July 28, 2020
NCT06082518
NCT07221162
NCT06721949
NCT06631287
NCT06679140
NCT06417762
Lead Sponsor
The University of Hong Kong
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions